Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Nivolumab and Ipilimumab in Brain Metastases
NCT04434560Phase 2Terminated
- Start
- Nov 2020
- Primary completion
- Jun 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab, ipilimumab in brain metastases. Started Nov 2020; status: terminated.
02
Drugs
nivolumabipilimumab
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT04434560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04434560.